Literature DB >> 21181983

Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care.

Christine G Gourin1, Arlene A Forastiere, Giuseppe Sanguineti, Wayne M Koch, Shanthi Marur, Robert E Bristow.   

Abstract

OBJECTIVE: To evaluate the impact of surgeon and hospital case volume and other related variables on short-term outcomes after surgery for laryngeal cancer.
METHODS: The Maryland Health Service Cost Review Commission database was queried for laryngeal cancer surgical case volumes from 1990 to 2009. Multivariate logistic regression analyses and multiple linear regression models were used to evaluate for significant associations between surgeon and hospital case volume, as well as other independent variables and the risk of in-hospital death, postoperative wound complications, length of hospital stay, and hospital-related cost of care.
RESULTS: Overall, 1,981 laryngeal cancer surgeries were performed with complete financial data available for 1,885 laryngeal cancer surgeries, performed by 284 surgeons at 37 hospitals. The only independently significant factor associated with the risk of in-hospital death was an APR-DRG mortality risk score of 4 (odds ratio [OR] = 10.7, P < .001). Postoperative wound fistula or dehiscence was associated with an increased mortality risk score (OR = 3.1, P < .001), total laryngectomy (OR = 12.4, P = .013), and flap reconstruction (OR = 3.8, P = .001). Increased mortality risk score, partial or total laryngectomy, flap reconstruction, and Black race were associated with an increased length of stay and hospital-related costs. After controlling for all other variables, a statistically significant negative correlation was observed between surgery at a high-volume hospital and both length of hospital stay (geometric mean = -1.5 days, P = .003). and hospital-related costs (geometric mean = -$6,061, P = .003).
CONCLUSIONS: After controlling for other factors, high-volume hospital care is associated with a shorter length of hospitalization and lower hospital-related cost of care for laryngeal cancer surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21181983     DOI: 10.1002/lary.21348

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  13 in total

1.  Health Services Research and Regionalization of Care-From Policy to Practice: the Ontario Experience in Head and Neck Cancer.

Authors:  Antoine Eskander; David P Goldstein; Jonathan C Irish
Journal:  Curr Oncol Rep       Date:  2016-03       Impact factor: 5.075

2.  [Laryngeal carcinoma: epidemiology, risk factors and survival].

Authors:  M Pantel; O Guntinas-Lichius
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

3.  Accuracy of the all patient refined diagnosis related groups classification system in congenital heart surgery.

Authors:  Aimee S Parnell; Justine Shults; J William Gaynor; Mary B Leonard; Dingwei Dai; Chris Feudtner
Journal:  Ann Thorac Surg       Date:  2013-11-05       Impact factor: 4.330

Review 4.  Defining value-driven care in head and neck oncology.

Authors:  Benjamin R Roman; Mahmoud I Awad; Snehal G Patel
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

5.  Multidisciplinary clinical approach to the management of head and neck cancer.

Authors:  Patrick J Bradley
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-16       Impact factor: 2.503

6.  Surgeon volume is associated with cost and variation in surgical treatment of proximal humeral fractures.

Authors:  Nitin B Jain; Ifedayo Kuye; Laurence D Higgins; Jon J P Warner
Journal:  Clin Orthop Relat Res       Date:  2012-07-24       Impact factor: 4.176

7.  Association of Hospital Volume With Laryngectomy Outcomes in Patients With Larynx Cancer.

Authors:  Christine G Gourin; C Matthew Stewart; Kevin D Frick; Carole Fakhry; Karen T Pitman; David W Eisele; J Matthew Austin
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-01-01       Impact factor: 6.223

8.  Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.

Authors:  Arun Sharma; Stephen M Schwartz; Eduardo Méndez
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

9.  Multilevel Associations Between Patient- and Hospital-Level Factors and In-Hospital Mortality Among Hospitalized Patients With Head and Neck Cancer.

Authors:  Eric Adjei Boakye; Nosayaba Osazuwa-Peters; Betty Chen; Miao Cai; Betelihem B Tobo; Sai D Challapalli; Paula Buchanan; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

10.  Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival.

Authors:  Evan M Graboyes; Mark A Ellis; Hong Li; John M Kaczmar; Anand K Sharma; Eric J Lentsch; Terry A Day; Chanita Hughes Halbert
Journal:  Cancer       Date:  2018-06-22       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.